Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(1):7; doi:10.1093/jnci/97.1.7
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zielinski, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zielinski, S. L.
Related Collections
Right arrowRelated News Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

2005 Medicare Payments for Chemotherapy Will Exceed Costs

Sarah L. Zielinski

The first 10% of the full text of this article appears below.

Medicare payments to oncologists for chemotherapy drugs will exceed costs by 6% in 2005, according to a new report from the Government Accounting Office (GAO). In addition, it found that fees for nearly every category of chemotherapy administration . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related News Article in JNCI

Medicare Demonstration Projects Acknowledge Evidence-Based Medicine in Cancer Care
Renee Twombly
J Natl Cancer Inst 2005 97: 6-7. [Extract] [Full Text] [PDF]